Publications

Some reports are in PDF format and need Adobe Acrobat Reader for viewing properly.
It can be downloaded free from Adobe website.

1. Vaidya PR, Jain AB , Thakur SS. Urinary Fistula: Study of 40 cases of vesico-vaginal fistula over a period of ten years at Nair Hospital , analyzing etiology, management and comparing the results. Journal of Post-Graduate Medicine , India 21:68-74, 1975 PubMed

2. McMaster P, Jurewig WA, Kirby RM, Jain AB, Augrisani L. The hazards of pancreatic transplantation complications of immunosuppressive therapy. Transplant Proc 43(4 Suppl 3):58-61, 1986.

3. Jain AB , Angrisani L, McMaster P. Staghorn calculus in renal allograft. Transplant Proc 18(4):959-962, 1986. PubMed

4. Angrisani L, Jurewicz WA, Clements 0G, Kirby RM, Jain AB, Elias E, McMaster P. Liver transplantation for liver cancers. Transplant Proc 18(5):1218-1219, 1986.

5. Brown P, Buckles JAC, Jain AB, McMaster P. Successful cadaveric renal transplant from a donor who died of cyanide poisoning. Brit Med J 294:1325, 1987. PubMed

6. Jain AB , Lee M, Bewar P, Chan SY. Primary angio-sarcoma of the spleen: A diagnosis to consider. Eur J Surg Oncol 14:341-343, 1988. PubMed

7. Jain AB, Buckles JAC, Adu D, Michael J, Mackintosh P, McMaster P. Long-term results of cyclosporine renal transplantation from a single center. Transplant Proc 20(3 Suppl 3):82-85, 1988. PubMed

8. Jain AB , Elias E, Gunson BK, Buckles JAC, McDowell B, Millis AH, McMaster P. Is elimination of cyclosporine in bile dependent on liver graft function and biliary drainage? Transplant Proc 20(2):516-522, 1988. PubMed

9. Jain AB , Young CH. Anterior transperitoneal approach to the upper urinary tract with one stage bilateral procedure. Brit J Urol 63:239-242, 1989. PubMed

10. Starzl TE, Todo S, Fung JJ, Demetris AJ, Venkataramanan R, Jain AB. FK 506 for liver, kidney, and pancreas transplantation. Lancet 2:1000-1004, 1989. PubMed

11. Fung JJ, Todo S, Jain AB, McCauley J, Alessiani M, Scotti C, Starzl TE. Conversion of liver allograft recipients with cyclosporine-related complications from cyclosporine to FK 506. Transplant Proc 22(1):6-12, 1990. PubMed

12. Todo S, Fung JJ, Demetris AJ, Jain AB, Venkataramanan R, Starzl TE. Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc 22(2):13-16, 1990. PubMed

13. McCauley J, Fung JJ, Jain AB, Todo S, Starzl TE. The effects of FK 506 upon renal function after liver transplantation. Transplant Proc 22(1):17-20, 1990. PubMed

14. Jain AB, Fung JJ, Venkataramanan R, Todo S, Alessiani M, Starzl TE. FK 506 dosage in human organ transplantation. Transplant Proc 22(1):23-24, 1990. PubMed

15. Shapiro R, Fung JJ, Jain AB, Parks P, Todo S, Starzl TE. The side effects of FK 506 in humans. Transplant Proc 22(1):35-36, 1990. PubMed

16. Van Thiel DH, Iqbal M, Jain AB, Fung JJ, Todo S, Starzl TE. Gastrointestinal and metabolic problems associated with immunosuppression with either cyclosporine or FK 506 in liver transplantation. Transplant Proc 22(1):37-40, 1990. PubMed

17. Alessiani M, Kusne S, Martin FM, Fung JJ, Jain AB, Todo S, Simmons R, Starzl TE. Infections under FK 506 immunosuppression: Preliminary results with primary therapy. Transplant Proc 22(1):44-46, 1990. PubMed

18. Staschak S, Wagner S, Block G, Van Thiel DH, Jain AB, Fung JJ, Todo S, Starzl TE. Cyclosporine as the primary immunosuppressive agent. Transplant Proc 22:47-49, 1990. PubMed

19. Venkataramanan R, Jain AB, Cadoff E, Fung JJ, Warty V, Krajack A, Imventarza O, Todo S, Fung JJ, StarzlTE. Pharmacokinetics of FK 506 Preclinical and Clinical Studies. Transplant Proc 22(1):52-56, 1990. PubMed

20. Jain AB, Venkataramanan R, Cadoff E, Fung JJ, Todo S, Krajack A, Starzl TE. Effect of hepatic dysfunction and T-tube clamping on FK 506 pharmacokinetics and trough concentrations. Transplant Proc 22(1):57-59, 1990. PubMed

21. Zeevi A, Eiras G, Burckart G, Jain AB, Krajack A, Venkataramanan R, Todo S, Fung JJ, Starzl TE, Duquesnoy RJ. Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression. Transplant Proc 22(1):60-63, 1990. PubMed

22. Burckart GJ, Jain AB , Diven W, Venkataramanan R, Starzl TE. Cyclosporine measurement by FPIA, PcRIA, and HPLC following liver transplantation. Transplant Proc 22:1319-1322, 1990. PubMed

23. Gunson BK, Jones SR, Buckles JAC, Jain AB, McMaster P. Liver Transplantation in Birmingham: use of Cyclosporine--Clinical correlation with drug monitoring. Transplant Proc 22:1312-1318, 1990 PubMed.

24. Todo S, Fung JJ, Starzl TE, Tzakis A, Demetris AJ, Kormos R, Jain AB, Alessiani M, Takaya S, Shapiro R. Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg 212(3):295-307, 1990. PubMed

25. Starzl TE, Fung JJ, Jordan M, Shapiro R, Tzakis A, McCauley J, Johnston J, Iwaki Y, Jain AB, Alessiani M, Todo S. Kidney transplantation under FK 506. JAMA 264:63-67, 1990 PubMed

26. Fung JJ, Abu-Elmagd K, Alessiani M, Armitage J, Bloom E, Bronsther O, Casavilla A, Demetris AJ, Gordon R, Hakala T, Imventarza O, Jaffe R, Jain AB, Jordan M, Kormos R, Martin M, McCauley J, Przepiorka D, Scantlebury V, Selby R, Shapiro R, Starzl TE, Staschak S, Stieber A, Todo S, Tzakis A, Van Thiel DH: Overview of FK 506 in transplantation. In: Terasaki PI, ed. Clinical Transplants 1990 Los Angeles , CA , UCLA Tissue Typing Laboratory, 1991:115-121. PubMed

27. Abu-Elmagd K, Fung JJ, Alessiani M, Jain AB, Venkataramanan R, Warty VS, Takaya S, Todo S, Shannon WD, Starzl TE. The effect of graft function on FK 506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation 52(1):71-77, 1991. PubMed

28. Jain AB, Fung JJ, Todo S, Alessiani M, Takaya S, Abu-Elmagd K, Tzakis AG, Starzl TE. Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. Transplant Proc 23(1 Pt. 2):928-930, 1991. PubMed

29. Venkataramanan R, Jain AB, Warty VW, Abu-Elmagd K, Furukawa H, Imventarza O, Fung JJ, Todo S, Starzl TE. Pharmocokinetics of FK 506 following oral administration: A comparison of FK 506 and cyclosporine. Transplant Proc 23:931-933, 1991. PubMed

30. Fung JJ, Todo S, Tzakis A, Demetris AJ, Jain AB, K Abu-Elmagd, M Alessiani, TE Starzl. Conversion of liver allograft recipients from cyclosporine to FK 506 based immunosuppression: Benefits and Pitfalls. Transplant Proc 23:14-21, 1991. PubMed

31. Todo S, Fung JJ, Tzakis A, Demetris A, Jain AB, Alessiani M, Takaya S, Starzl TE. 110 consecutive primary orthotopic liver transplantation under FK 506 in adults. Transplant Proc 23:1399-1402, 1991. PubMed

32. Alessiani M, Kusne S, Martin M, Jain AB, Abu-Elmagd K, Moser J, Fung JJ, Starzl TE. Infection in adult liver transplant patients under FK 506 immunosuppression. Transplant Proc 23:1501-1503, 1991. PubMed

33. McCauley J, Takaya S, Fung JJ, Tzakis A, Abu-Elmagd K, Jain AB, Todo S, Starzl TE. The question of FK 506 nephrotoxicity. Transplant Proc 23:1444-1447, 1991. PubMed

34. Kusne S, Martin M, Shapiro R, Jordan M, Fung JJ, Alessiani M, Jain AB, Todo S, Starzl TE. Early infections in kidney transplant recipients under FK 506. Transplant Proc 23:956-957, 1991. PubMed

35. Zeevi A, Eiras G, Kaufman C, Alessiani M, Demetris AJ, Abu-Elmagd K, Jain AB, Warty V, Venkataramanan R, Burckart G, Starzl TE, Todo S, Fung JJ, Duquesnoy R. Correlation between bioassayed plasma levels of FK 506 and lymphocyte growth from liver transplant biopsies with histological evidence of rejection. Transplant Proc 23:1406-1408, 1991. PubMed

36. Fung JJ, Todo S, Tzakis A, Alessiani M, Abu-Elmagd K, Jain AB, Bronsther O, Martin M, Gordon R, Starzl TE. Current status on FK 506 in liver transplantation. Transplant Proc 23:1902-1905, 1991. PubMed

37. Alessiani M, Jain AB, Abu-Elmagd K, Todo S, Fung JJ, Starzl TE. An overview on clinical organ transplantation under FK 506. Transplant Clin Immunol 22:135-143, 1991.

38. Fung JJ, Abu-Elmagd K, Todo S, Shapiro R, Tzakis A, Jordan M, Armitage J, Jain AB, Martin M, Bronster O, Stieber A, Kormos R, Selby R, Gordon R, Starzl TE: Current status on FK 506 in organ transplantation. In: Chatelain C, Jacobs CL, eds. Seminaires D'Uro-Nephrologie. Paris , France , Masson, 1991:196-201.

39. Steeves M, Abdallah HY, Venkataramanan R, Burckart GJ, Ptachcinski RJ, Abu-Elmagd K, Jain AB, Fung JJ, Todo S, Starzl TE. In-vitro interaction of a novel immunosuppressant, FK 506, and antacids. J Pharm Pharmacol 43:574-577, 1991. PubMed

40. Fung JJ, Abu-Elmagd K, Jain AB, Gordon R, Tzakis A, Todo S, Takaya S, Alessiani M, Demetris AJ, Bronsther OL, Martin M, Mieles L, Selby R, Reyes J, Doyle H, Stieber A, Casavilla A, Starzl TE. A randomized trial of primary liver transplantation under immunosuppression with FK 506 versus cyclosporine. Transplant Proc 23(6):2977 -2983, 1991 PubMed.

41. Jordan ML, Shapiro R, Jensen CWB, Scantlebury V, Fung JJ, Tzakis A, McCauley J, Jain AB, Demetris AJ, Randhawa P, Simmons RL, Hakala TR, Starzl TE FK 506 conversion of renal allografts failing cyclosporine immunosuppression. Transplant Proc 23(6):3078-3081, 1991. PubMed

42. Abu-Elmagd K, Fung JJ, Draviam R, Shannon W, Jain AB, Alessiani M, Takaya S, Venkataramanan R, Warty VS, Tzakis AG, Todo S, Starzl TE. Four-hour versus 24-hour intravenous infusion of FK 506 in liver transplantation. Transplant Proc 23(6):2767-2770, 1991. PubMed

43. Abu-Elmagd K, Fung JJ, Alessiani M, Jain AB, Takaya S, Venkataramanan R, Warty VS, Shannon W, Todo S, Tzakis AG, Van Thiel DH, Starzl TE. Strategy of FK 506 therapy in liver transplant patients: Effect of graft function. Transplant Proc 23(6):2771-2774, 1991. PubMed

44. Demetris AJ, Fung JJ, Todo S, McCauley J, Jain AB, Takaya S, Alessiani M, Abu-Elmagd K, Van Thiel DH, Starzl TE. FK 506 used as rescue therapy for human liver allograft recipients. Transplant Proc 23(6):3005-3006, 1991. PubMed

45. Alessiani M, Kusne S, Fung JJ, Torre-Cisneros J, Jain AB, Abu-Elmagd K, Takaya S, Cillo U, Martin M, Todo S, Starzl TE. CMV infection in liver transplantation under cyclosporine or FK 506 immunosuppression. Transplant Proc 23:3035-3037, 1991. PubMed

46. Eidelman BH, Abu-Elmagd K, Wilson J, Fung JJ, Alessiani M, Jain AB, Takaya S, Todo SN, Tzakis AG, Van Thiel DH, Shannon W, Starzl TE. Neurological complications of FK 506. Transplant Proc 23(6):3175-3178, 1991. PubMed

47. Fung JJ, Alessiani M, Abu-Elmagd K, Todo S, Shapiro R, Tzakis AG, Van Thiel D, Armitage J, Jain AB, McCauley J, Selby R, Starzl TE. Adverse effects associated with the use of FK 506. Transplant Proc 23(6):3105-3108, 1991. PubMed

48. Jain AB, Fung JJ, Tzakis AG, Venkataramanan R, Abu-Elmagd K, Alessiani M, Reyes J, Irish W, Warty V, Mehta S, Todo S, Starzl TE. Comparative study of cyclosporine and FK 506 dosage requirements in adults and pediatric orthotopic liver transplant patients. Transplant Proc 23:2763-2766, 1991. PubMed

49. Jain AB, Todo S, Fung JJ, Venkataramanan R, Day R, Bryant J, Abu-Elmagd KM, Alessiani M, Takaya S, Tzakis A, Starzl TE. Correlation of rejection episodes with FK 506 dosage, FK 506 level and steroid following primary orthotopic liver transplant. Transplant Proc 23(6):3023-3025, 1991. PubMed

50. Jain AB, Venkataramanan R, Fung JJ, Burckart G, Emeigh J, Diven W, Warty V, Abu-Elmagd K, Todo S, Alessiani M, Starzl TE. Pharmacokinetics of cyclosporine and nephrotoxicity in orthotopic liver transplant patients rescued with FK 506. Transplant Proc 23(6):2777-2779, 1991. PubMed

51. Roat MI, Thoft RA, Thomson AW, Jain AB, Fung JJ, Starzl TE. Treatment of Cogan's syndrome with FK 506: A case report. Transplant Proc 23(6):3347, 1991. PubMed

52. Shapiro R, Jordan M, Scantlebury V, Fung JJ, Jensen C, Tzakis A, McCauley J, Carroll P, Ricordi C, Demetris AJ, Mitchell S, Jain AB, Iwaki Y, Kobayashi M, Reyes J, Todo S, Hakala TR, Simmons RL, Starzl TE. FK 506 in clinical kidney transplantation. Transplant Proc 23(6):3065-3067, 1991.

53. Tzakis AG, Reyes J, Todo S, Green M, Ohya T, Jain AB, Abu-Elmagd K, Alessiani M, Fung JJ, Starzl TE. FK 506 versus cyclosporine in pediatric liver transplantation. Transplant Proc 23(6):3010-3015, 1991. PubMed

54. Tauxe WN, Mochizuki T, McCauley J, Starzl TE, Jain AB, Charron M. A comparison of the renal effects (ERPF, GFR, FF) of FK 506 and cyclosporine in patients with liver transplantation. Transplant Proc 23(6):3146-3147, 1991. PubMed

55. Venkataramanan R, Jain AB, Warty VS, Abu-Elmagd K, Alessiani M, Lever J, Krajak A, Flowers J, Mehta S, Zuckerman S, Fung JJ, Todo S, Starzl TE. Pharmacokinetics of FK 506 in transplant patients. Transplant Proc 23(6):2736-2740, 1991. PubMed

56. Whiteside, J Wilson, J Bryant, A Zeevi, K Abu-Elmagd, AB Jain, M Alessiani, JJ Fung, RB Herberman, TE Starzl. Serial monitoring of immunologic function and phenotype of lymphocytes in the blood or transplanted patients randomized to cyclosporin A or FK 506. Transplant Proc 23(6):3047-3051, 1991. PubMed

57. McCauley J, Fung JJ, Brown H, Deballi P, Jain AB, Todo S, Starzl TE. Renal function after conversion from cyclosporine to FK 506 in liver transplant patients. Transplant Proc 3(6):3148-3149, 1991. PubMed

58. McCauley J, Shapiro R, Bronsther O, Jordan M, Ellis D, Gilboa N, Scantlebury V, Jensen C, Jain AB, Starzl TE. Renal transplantation under FK 506 in patients with previous loss of renal function due to hemolytic uremic syndrome. Transplant Proc 23(6):3068-3070, 1991.

59. McCauley J, Fung JJ, Todo S, Jain AB, Deballi P, Starzl TE. Changes in renal function after liver transplantation under FK 506. Transplant Proc 23(6):3143-3145, 1991. PubMed

60. Fung JJ, Abu-Elmagd K, Todo S, Shapiro R, Tzakis A, Jordan M, Armitage J, Jain AB, Martin M, Bronsther O, Stieber A, Kormos R, Selby R, Gordon R, Starzl TE. FK 506 in clinical organ transplantation. Clin Transplant 5:517-522, 1991.

61. Demetris AJ, Fung JJ, Todo S, McCauley J, Jain AB, Takaya S, Alessiani M, Abu-Elmagd K, Van Thiel DH, Starzl TE. Conversion of liver allograft recipients from cyclosporine to FK 506 immunosuppressive therapy--A clinicopathologic study of 96 patients. Transplantation 53:1056-1062, 1992. PubMed

62. Takaya S, Bronsther O, Todo S, Abu-Elmagd K, Jain AB, Alessiani M, Madariaga J, Marino IR, Selby R, Fung JJ, Gordon RD, Starzl TE. Retransplantation of liver: A comparison of FK 506-and cyclosporine-treated patients. Transplant Proc 23(6):3026-3028, 1991. PubMed

63. Felser I, Wagner S, Depee J, Johnson N, Staschak S, Jain AB , Fung JJ, Starzl TE. Changes in quality of life following conversion from CYA to FK 506 in orthotopic liver transplant patients. Transplant Proc 23(6):3032-3034, 1991. PubMed

64. Zeevi A, Venkataramanan R, Warty V, Eiras G, Woan M, Abu-Elmagd K, Alessiani M, Jain AB, Demetris AJ, Zerbe T, Fung JJ, Todo S, Starzl TE, Duquesnoy RJ. In vitro assessment of FK 506 immunosuppressive activity in transplant patients. Transplant Proc 3:2897-2899, 1991. PubMed

65. Reyes J, Abu-Elmagd K, Tzakis A, Nour B, Casavilla A, Kusne S, Green M, Alessiani M, Jain AB, Fung JJ, Todo S, Starzl TE. Infectious complications after human small bowel transplantation. Transplant Proc 24(3):1249-1250, 1992. PubMed

66. Jain AB, Venkataramanan R, Todo S, Abu-Elmagd K, Fung JJ, Warty V, Tzakis A, Reyes J, Alessiani M, Starzl T. Intravenous, oral pharmacokinetics and oral dosing of FK 506 in small bowel transplant patients. Transplant Proc 24(3):1181-1182, 1992. PubMed

67. Kusne S, Fung JJ, Alessiani M, Martin M, Torre-Cisneros J, Irish W, Ondick L, Jain AB, Abu-Elmagd K, Takaya S, Todo S, Starzl TE. Infections during a randomized trial comparing cyclosporine to FK 506 immunosuppression in liver transplantation. Transplant Proc 24(1):429-430, 1992. PubMed

68. Todo S, Tzakis AG, Abu-Elmagd K, Reyes J, Fung JJ, Casavilla A, Nakamura K, Yagihashi A, Jain AB, Murase N, Iwaki Y, Demetris AJ, Van Thiel DH, Starzl TE. Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation 53(2):369-376, 1992. PubMed

69. Shapiro R, Jordan ML, Scantlebury VP, Fung JJ, Jensen C, Vivas C, McCauley J, Irish WD, Mitchell S, Demetris AJ, Randhawa P, Jain AB, Tzakis A, Hakala TR, Simmons RL, Starzl TE. Randomized trial of FK 506/Prednisone versus FK 506/Azathioprine/Prednisone after renal transplantation: Preliminary report. Transplant Proc 25(1 Pt. 1):669-672, 1993.

70. Alessiani M, Cillo U, Fung JJ, Irish W, Abu-Elmagd K, Jain AB, Takaya S, Van Thiel D, Starzl TE: Adverse effects of FK 506 overdosage after liver transplantation. Transplant Proc 25(1 Pt 1):628-634, 1993. PubMed

71. Jain AB, Venkataramanan R, Lever J, Warty V, Fung JJ, Todo S, Starzl TE. FK 506 and pregnancy in liver transplant patients. Transplantation 56(3):751, 1993. PubMed

72. Fung JJ, Todo S, Abu-Elmagd K, Jain AB, Tzakis A, Martin M, Selby R, Bronsther O, Doyle H, Gayowski T, Ramos H, Kishida A, Starzl TE. A randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine. Transplant Proc 25(1 Pt. 2):1130, 1993. PubMed

73. Jain AB , Abu-Elmagd K, Abdallah H, Warty V, Fung JJ, Todo S, Starzl TE, Venkataramanan R. Pharmacokinetics of FK 506 in liver transplant recipients following continuous intravenous infusion. J Clin Pharmacol 33(7):606-611, 1993. PubMed

74. Abu-Elmagd K, Bronsther OL, Jain AB, Irish W, Ramos H, Marino I, Dodson F, Selby R, Doyle H, Furukawa H, Gaywoski T, Nour B, Reyes J, Mazariegos G, Pinna A, Rao AS, Fontes PA, Casavilla A, Jabbour N, Marsh W, Madariaga J, Demetris A, Tzakis A, Todo S, Iwatsuki S, Fung JJ, Starzl TE: Recent Advances in Hepatic Transplantation at the University of Pittsburgh. In: Terasaki and Cecka, eds. Clinical Transplants 1993 Los Angeles , CA , UCLA Tissue Typing Laboratory, 1993:137-152. PubMed

75. Jain AB. Incidence and severity of rejection under Alpha Interferon for viral hepatitis following liver transplantation. Liver update, Function and Disease 7(1):5, 1993.

76. Venkataramanan R, Lever J, Jain AB, Burckart G, Flowers J, Warty VS, Fung JJ, Todo S, Starzl TE. FK 506: Correlation between trough concentration and AUC in transplant patients. Pharm Res 10(10):390, 1993.

77. Jain AB, Venkataramanan R, Lever J, Warty V, Abu-Elmagd K, Furukawa H, Reyes J, Nour B, Asrian A, Tzakis A. FK 506 in small bowel transplant recipients: Pharmocokinetics and dosing. Transplant Proc 25(3):1609-1610, 1994. PubMed

78. Manez R, Martin M, Raman D, Silverman D, Jain AB, Warty V, Gonzalez-Pinto I, Kusne S, Starzl TE. Fluconazole therapy in transplant recipients receiving FK 506. Transplantation 57(10):1521-1523, 1994. PubMed

79. Todo S, Fung JJ, Starzl TE, Tzakis A, Doyle H, Abu-Elmagd K, Jain AB, Selby R, Bronsther O, March W, Ramos H, Reyes J, Gayowski T, Casavilla A, Dodson F, Furukawa H, Marino I, Pinna A, Nour B, Jabbour N, Mazariegos G, McMichael J, Kusne S, Venkataramanan R, Warty V, Murase N, Demetris AJ, Iwatsuki S. Single center experience with primary orthotopic liver transplantation under FK 506 immunosuppressive. Ann Surg 220(3):297-309, 1994. PubMed

80. Shapiro R, Jordan ML, Scantlebury VP, Vivas C, Fung JJ, McCauley J, Randhawa P, Demetris AJ, Irish W, Jain AB, Mitchell S, Hakala TR, Simmons RL, Starzl TE. A prospective, randomized trial of FK 506/Prednisone versus FK 506/Azathioprine/Prednisone in renal transplant patients. Transplant Proc 27(1):814-817, 1995 PubMed.

81. Jain AB, Fung JJ, Todo S, Reyes J, Selby R, Irish W, Doyle H, Abu-Elmagd K, Casavilla A, Nour B, Bronsther O, Jabbour N, Pinna A, Dodson F, Ramos H, McMichael JJ, McCauley J, Tzakis AG, Marino I, Marsh W, Venkataramanan R, Iwatsuki S, Starzl TE. One thousand consecutive primary orthotopic liver transplants under FK 506: Survival and adverse events. Transplant Proc 27(1):1099-1104, 1995. PubMed

82. Bronsther O, Manez R, Kusne S, Irish W, Roland W, Jain AB, Demetris AJ, Starzl TE. Post-transplant B, Non-A Non-B, and cytomegalovirus hepatitis increases the risk of developing chronic rejection after liver transplantation. Transplant Proc 27(1):1206-1207, 1995. PubMed

83. Jain AB, Pinna A, Fung JJ, Warty VS, Singhal AK, Lever J, Venkataramanan R. Capillary blood versus arterial or venous blood for tacrolimus monitoring in liver transplantation. Transplantation 60:512-514, 1995. PubMed

84. Tsamandas A, Jain AB, Raikow RB, Demetris AJ, Nalesnik MA, Randhawa PS. Extra medullary hematopoiesis in the allograft liver. Modern Pathol 8(6):671-674, 1995. PubMed

85. Manez R, Jain AB , Marino IR, Thomson A. Comparative evaluation of tacrolimus (FK 506) and cyclosporine A as immunosuppressive agents (review). Transplant Rev 9(2):63-76, 1995.

86. Venkataramanan R, Swaninathan A, Prasad T, Jain AB, Zuckerman S, Warty VS, McMichael J, Lever J, Burckart G, Starzl TE. Clinical Pharmacokinetics of Tacrolimus. Clin Pharmacokinetic 29(6):404-430, 1995. PubMed

87. Pham SM, Kormos R, Hatler BG, Kawai A, Tasamandas AC, Demetris AJ, Murali S, Fricker FJ, Chang HC, Jain AB, Starzl TE, Hardesty RL, Griffith BP. Cardiac and pulmonary replacement: A prospective trial of tacrolimus (FK 506) in clinical heart transplantation: Intermediate-term results. J Thoracic Cardiovasc Surg 111(4):764-772, 1996. PubMed

88. Jain AB, Fung JJ. Cyclosporine and tacrolimus in clinical transplantation: A comparative review. Clin Immunother (5):351-373, 1996.

89. Abu-Elmagd, K, Fung J, Todo S, Rao A, Reyes J, Mazariegos G, Fontes P, McMichael J, Furukawa H, Dodson F, Jain AB, Pinna A, Marsh W, Marino I, Gayowski T, Doyle H, adariaga J, Casavilla A, Demetris J, Corry R, Rakela J, Iwatsuki S, Starzl TE. The current status of hepatic transplantation at the University of Pittsburgh . In: Clinical Transplants 1995 (P Terasaki, F Cecka, eds.), UCLA Tissue Typing Laboratory, Los Angeles , CA , 1995:145-170.

90. Fung JJ, Todo S, Jain AB, Demetris AJ, McMichael JP, Starzl TE. The Pittsburgh randomized trial of tacrolimus versus Cyclosporine for liver transplantation. J Am Coll Surg 183(2)117-125, 1996. PubMed

91. Tabasco-Minguillan J, Jain AB, Naik M, Weber KM, Irish W, Fung JJ, Rakela J, Starzl TE. Gastrointestinal bleeding after liver transplantation. Transplantation 63(1):60-67, 1997. PubMed

92. Khanna A, Jain AB, Ziady G, Demetris AJ, Fung JJ, Kramer D, Starzl TE. Cardiac changes at autopsy in adult liver transplant recipients under tacrolimus. Transplant Proc 29(1-2):532-533, 1997. PubMed PDF

93. Jain AB, Venkataramanan R, Fung JJ, Gartner JC, Lever J, Balan V, Warty V, Starzl TE. Pregnancy after liver transplantation under tacrolimus. Transplantation 64(4):559-565, 1997. PubMed

94. Tsamandas AC, Jain AB, Felekouras ES, Fung JJ, Demetris AJ, Lee RG: Central venulitis in the allograft liver. Transplantation 64(2):252-257, 1997. PubMed

95. Jain AB, Demetris AJ, Manez R, Tsamanadas AC, Van Thiel D, Rakela J, Starzl TE, Fung JJ. Incidence and severity of acute allograft rejection in liver transplant recipients treated with alpha-interferon. Liver Transplantation and Surg 4(3):197-203, 1998. PubMed

96. Jain AB, Hamad I, Rakela J, Dodson F, Kramer D, Demetris J, McMichael J, Starzl TE, Fung JJ. A prospective randomized trial of tacrolimus and Prednisone versus tacrolimus, Prednisone and Mycophenolate Mofetil in primary adult liver transplant recipients: an interim report. Transplant Proc (33):1342-1344, 2001. PubMed PDF

97. Torbenson M, Wang J, Nichols L, Jain AB, Fung JJ, Nalesnik MA. Causes of death in autopsied liver transplant patients. Mod Pathol 11(1):37-46, 1998. PubMed

98. Burckart GJ, Frye RF, Kelly P, Branch RA, Jain AB , Fung JJ, Starzl TE, Venkataramanan R. Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6- hydroxylation. Clin Pharmacol Ther 63(3):296-302, Mar, 1998. PubMed

99. Jain A, Reyes J, Kashyap R, Rohal S, Cacciarelli T, McMichael J, Rakela J, Starzl TE, FungJJ. Liver transplantation under tacrolimus in infants, children, adults and seniors: long-term results, survival, and adverse events in 1000 consecutive patients. Transplant Proc 30(4):1403-1404, 1998. PubMed PDF

100. DiMartini A, Jain AB , Irish W, Fitzgerald MG, Fung JJ. Outcome of liver transplantation in critically ill alcoholic cirrhotics: Survival according to medical variables and society. Transplantation 66(3):298-302, 1998. PubMed

101. Jain AB, Yee LD, Nalesnik MA, Youk A, Marsh J, Reyes J, Rakela J, Irish W, Fung JJ. Comparative incidence of de novo non-lymphoid malignancies after liver transplantation under Tacrolimus using surveillance epidemologic end-result data. Transplantation 66(9):1193-1200, 1998. PubMed

102. Cacciarelli TV, Green M, Jaffee R, Mazariegos GV, Jain AB, Fung JJ, Reyes J. Management of post-transplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. Transplantation 66(8):1047-1052, 1998. PubMed

103. Abu-Elmagd K, Fung J, Reyes J, Rao A, Jain AB, Mazariegos G, Marsh J, Madariaga J, Dvorchik I, Bueno J, Rogers J, McMichael J, Dodson F, Vargus H, Martin J, Slivka A, Balan V, Corry R, Rakela J, Murase N, Iwatsuki S, Starzl T. Hepatic and intestinal transplantation at the University of Pittsburgh. Clin Transpl 263-286, 1998. PubMed

104. Jain AB , Gadomski M, Fung, JJ. Conversion from cyclosporine to Neoral in stable adult liver transplant recipients. DigDisSci 44(4):775-77, 1999. PubMed

105. Jain AB, Fung JJ, Kashyap R, Rakela J, Starzl TE. Primary adult liver transplantation under tacrolimus: More than 90 months’ actual follow-up survival and adverse events. Liver Transpl Surg 5(2):144-150, 1999. PubMed

106. Molmenti E, Jain AB, Marino N, Rishi N, Dvorchik I, Marsh J. Liver transplantation and pregnancy. Clin Liver Dis 3(1):163-174, 1999.

107. Jain AB , Khanna A, Molmenti EP, Rishi N, Fung JJ. Immunosuppressive therapy: New concepts. Surg Clin North Amer 79(1):59-76, 1999. PubMed

108. Jain AB, Hamad I, Zuckerman S, Warty VS, Fung JJ, Venkataramanan R. Effect of T-tube clamping on the pharmacokinetics of mycophenolic acid in liver transplant patients on oral therapy of mycophenolate mofetil. Liver Transpl Surg 5(2):101-106, 1999. PubMed

109. Jain AB, Reyes J, Kashyap R, Rohal S, Abu-Elmagd K, Starzl TE, Fung JJ. What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow up of the first 1000 patients. Ann Surg 230(3):441-449, 1999. PubMed PDF

110. Cacciarelli TV, Dvorchik K, Mazariegos GV, Gerber D, Jain AB, Fung JJ, Reyes J. An analysis of pre-transplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK 506) therapy. Transplantation 68(5):650-655, 1999. PubMed

111. Jain AB , Venkataramanan R, Hamad IS, Zuckerman S, Zhang S, Lever J, Warty VS, Fung JJ. Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus. J Clin Pharmacol 41(3)268-276, 2001. PubMed PDF

112. Jain AB , Kashyap R, Fung JJ: Current perspective on immunosuppression used in liver transplantation with emphasis on neurotoxicity. Gastroenterol Intern 12(3):115-122, 1999.

113. Takaya S, Jain A, Yagihashi A, Nakamura K, Kobayashi M, Tekeuchi K, Suzuki S, Iwaki Y, Demetris AJ, Todo S, Fung JJ, Starzl TE. Increased bile duct complications and/or chronic rejection in crossmatch-positive human liver allografts. Transplant Proc 31(5):2028-2031, 1999. PubMed PDF

114. Molmenti E, Mazariegos G, Bueno J, Cacciarelli T, Alasia T, Khanna A, Kosmach B, Jain A, Fung J, Reyes J. Noncompliance after pediatric liver transplantation. Transplant Proc 31(1-2):408, 1999. PubMed PDF

115. Khanna A, Jain A, Eghtesad B, Rakela J. Liver transplantation for metabolic liver diseases. Surg Clin North Am 79(1):59-76, 1999. PubMed

116. Shapiro R, Jordan ML, Scantlebury VP, Vivas CA, Jain AB, Chakrabarti P, McCauley J, Johnston J, Randhawa P, Rao A, Fung JJ, Corry RJ. Simultaneous pancreas-kidney transplantation at the University of Pittsburgh . Clin Transpl 217-221, 1999. PubMed

117. Jain AB, Hamad I, Brody D, Fung JJ. Conversion to Neoral for neurotoxicity after primary adult liver transplantation under tacrolimus. Transplantation 69(1):172-176, 2000. PubMed

118. Jain AB , Kashyap R, Fung JJ. An overview of liver transplantation under tacrolimus. Journal of Transplantation in Developing Nations 2(1-2):7-12, March-June 2001.

119. Shapiro R, Nalesnik M, McCauley J, Fedorek S, Jordan ML, Scantlebury VP, Jain AB , Vivas C, Ellis D, Lombardozzi-Lane S, Randhawa P, Johnston J, Hakala TR, Simmons RL, Fung JJ, Starzl TE: Post-transplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 1999; 68(12):1851-1854. PubMed

120. Jain A, DiMartini A, Kashyap R, Youk A, Rohal S, Fung JJ. Long-term follow up after liver transplantation for alcoholic liver disease under tacrolimus. Transplantation 2000; 70(9):1335-1342. PubMed PDF

121. Reyes J, Jain AB, Mazariegos G, Kashyap R, Green M, Iurlano K, Fung JJ. Long-term results after conversion from Cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection. Transplantation 69(12):2573-2580, 2000. PubMed

122. Jain AB, Mazariegos G, Kashyap R, Green M, Gronsky C, Starzl TE, Fung JJ, Reyes J. Comparative long-term evaluation of tacrolimus and Cyclosporine in pediatric liver transplantation. Transplantation 70(4):617-625, 2000. PubMed PDF

123. Blakolmer K, Jain AB, Ruppert K, Gray E, Duquesnoy R, Murase N, Starzl TE, Fung JJ, Demetris JJ. Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: Long-term follow up and evaluation of features for histopathological staging. Transplantation 69(11):2330-2336, 2000. PubMed

124. Jain AB, Mazariegos G, Kashyap R, Marsh J, Khanna A, Iurlano K, Fung JJ, Reyes J. Reasons why some children receiving tacrolimus therapy require steroids more than five years post-liver transplantation. Ped Transplantation 5:93-98, 2001. PubMed

125. Jain AB, Reyes J, Kashyap R, Dodson F, Demetris AJ, Ruppert K, Abu-Elmagd K, Marsh J, Madariaga J, Mazariegos G, Geller D, Bonham AC, Gayowski T, Cacciarelli T, Fontes P, Starzl TE, Fung JJ. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg 232(4):490-500, 2000. PubMed PDF

126. DiMartini A, Magill J, Fitzgerald MG, Jain AB, Irish W, Khera G, Yates W. Use of a high-risk alcohol relapse scale in evaluating liver transplant candidates. Alcoholism: Clinical & Experimental Research 24(8):1198-1201, 2000. PubMed PDF

127. Jain AB, Kashyap R, Marsh J, Rohal S, Khana A, Fung JJ. Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus. Transplantation 71(8):1102-1106, 2001. PubMed PDF

128. Luke PPW, Scantlebury VP, Jordan ML, Vivas CA, Hakala TR, Jain AB, Somani A, Fedorek S, Randhawa P, Shapiro R. Reversal of steroid and anti-lymphocyte antibody-resistant rejection using intravenous immunoglobulin (IVIG) in renal transplant recipients. Transplantation 2001;72(3); 419-422. PDF

129. Kashyap R, Jain AB, Reyes J, Demetris AJ, Abu-Elmagd KA, Dodson SF, Marsh J, Madariaga J, Mazariegos G, Geller D, Bonham, CA, Cacciarelli T, Fontes P, Starzl TE, Fung JJ. Causes of re-transplantation after primary liver transplantation in 4000 consecutive patients: 2 to 19 years follow-up. Transplant Proc 33(1-2):1486-1487, 2001. PubMed PDF

130. Kashyap R, Jain AB, Reyes J, Demetris AJ, Abu-Elmagd K, Dodson S, Marsh J, Mazariegos G, Geller D, Bonham CA, Cacciarelli T, Fontes P, Starzl TE, Fung JJ. Causes of death after liver transplantation in 4,000 consecutive patients: 2-19 years’ follow up. Transplant Proc 33(1-2) 1482-1483, 2001. PubMed PDF

131. Jain AB, Kashyap R, Kramer D, Dodson F, Hamad I, Starzl TE, Fung JJ Prospective randomized trial of tacrolimus and Presdnisone versus tacrolimus, Prednisone and mycophenolate mofetil: A complete report on 350 primary adult liver transplantations. Transplant Proc 33(1-2)1342-1344, 2001. PubMed PDF

132. Torbenson M, Wank J, Nichols L, Jain AB, Fung JJ, Nalesnik MA. Occult non-hematopoietic malignancies present at autopsy in solid-organ transplant patients who died within 100 days. Transplantation 71(1):64-69, 2001 PubMed PDF

133. Molmenti EP, Jain AB, Shapiro R, Scantlebury V, Lee R, Totsuka E, Flohr J, Rakela J, Fung JJ. Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitus C viral infection. Transplantation 71(2):267-270, 2001. PubMed PDF

134. DiMartini A, Day N, Dew MA, Lane T, Fitzgerald MG, Magill J, Jain AB. Alcohol use following liver transplantation: A comparison of follow-up methods. Psychosomatics 42(a):55-62, 2001. PubMed PDF

135. Randhawa P, Blakolmer K, Kashyap R, Raikow R, Nalesnik, M, Demetris AJ, Jain AB. Allograft liver biopsy in patients with Epstein-Barr virus-associated post-transplant lymphoproliferative disease. Am J Surg Pathol (3)324-330, 2001. PubMed PDF

136. Luke PPW, Scantlebury VP, Jordan ML, Vivas CA, Hakala TR, Jain AB, Somani A, Fedorek S, Randhawa P, Shapiro R. IVIG rescue therapy in renal transplantation. Transplant Proc 33:1093-1094, 2001. PubMed PDF

137. McCauley J, Shapiro R, Jordan ML, Scantlebury VP, Vivas V, Jain AB, Good D, Woods H, Johnston J, Corry RJ. Long-term lipid metabolism in combined kidney-pancreas transplant recipients under tacrolimus immunosuppression. Transplant Proc 33:1698-1699, 2001. PubMed PDF

138. Shapiro R, Rao AS, Corry RJ, Valenti M, Zeevi A, Jordan ML, Scantlebury VP, Vivas A, Jain AB, McCauley J, Randhawa P, Gray EA, Dvorchik I, McMichael J, Fung JJ, Starzl TE. Kidney transplantation with bone marrow augmentation: five year outcomes. Transplant Proc 33(1-2)1134-1135, 2001. PubMed PDF

139. Chakrabarti P, Wong HY, Toyofuku A, Scantlebury VP, Jordan ML, Vivas C, Jain AB, McCauley J, Johnston J, Randhawa PS, Hakala TR, Simmons RL, Fung JJ, Starzl TE, Shapiro R. Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc 33(1-2):1235-1236, 2001. PubMed PDF

140. Shapiro R, Randhawa P, Jordan ML, Scantlebury VP, Vivas C, Jain AB, Corry RJ, McCauley J, Johnston J, Donaldson J, Gray EA, Dvorchik I, Hakala TR, Fung JJ, Starzl TE. An analysis of early renal transplant protocol biopsies—the high incidence of subclinical tubulitis. Am J Transplantation 1(1):47-50, 2001. PubMed

141. Jain AB, Demetris A, Kashyap R, Blakomer K, Ruppert K, Khan A, Rohal S, Starzl TE, Fung JJ. Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1048 liver transplantations with a mean follow up of six years. Liver Transplantation 7(7):623-630, 2001. PubMed PDF

142. Cacciarelli TV, Reyes J, Jaffe R, Mazariegos GV, Jain AB, Fung JJ, Green M. Primary tacrolimus (FK 506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients. Ped Transplantation 5:359-364, 2001. PubMed

143. Bellamy COC, DiMartini AM, Ruppert K, Jain AB, Dodson F, Torbenson M, Starzl TE, Fung JJ, Demetris AJ. Liver transplantation for alcoholic cirrhosis: Long-term follow up and impact of disease recurrence. Transplantation 72(4):619-626, 2001. PubMed

144. Jain AB, Kashyap R, Dodson SF, Kramer D, Hamad I, Khan A, Eghtesad B, Starzl TE, Fung JJ. A prospective randomized trial of tacrolimus and Prednisone versus tacrolimus, Prednisone and mycophenolate mofetil in primary adult liver transplantation: A single center report. Transplantation 72(6); 1091-1097, 2001. PubMed

145. Jain AB , Mazariegos G, Kashyap R, Beverly K, Starzl TE, Fung JJ, Reyes J. Pediatric liver transplantation: A single center experience spanning 20 years. Transplantation 73:(6):941-947, March 27, 2002. PubMed PDF

146. Daly I, Jain AB, Reyes J, Fung JJ. Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus. Transplant Proc 34:1503 (2002). PDF

147. Jain AB, Mazariegos G, Pokharna R, Parizhskaya M, Smith A, Kashyap RS, Fung J J, Reyes, J. Almost Total Absence of Chronic Rejection in Primary Pediatric Liver Transplantation Under Tacrolimus. Transplant Proc 34:1968-1969 (2002). PubMed PDF

148. Jain AB , Mazariegos G, Kashyap RS, Kosmach-Park B, Starzl TE, Fung JJ, Reyes J. Pediatric Liver Transplantation in 808 Consecutive Children: 20 Years’ Experience From a Single Center , Transplant Proc 34:1955-1957 (2002). PubMed PDF

149. Jain AB, Venkataramanan R, Shapiro R, Scantlebury VP, Potdar S, Bonham CA, Pokharna R, Rohal S, Ragni M, Fung JJ. The Interaction Between Tacrolimus and Anti-Retroviral Agents in HIV-Positive Liver and Kidney Transplant Patients. Transplant Proc 34:1540-1541 (2002). PubMed PDF

150. Jain AB , Pokharna R, Eghtesad B, Potdar S, Kashyap RS, Kingery L, Fung JJ. Steroid Withdrawal Under Tacrolimus for Primary Biliary Cirrhosis (PBC), Primary Sclerosing Cholangitis (PSC) and Autoimmune Hepatitis (AIH) After Liver Transplantation and Long-Term Survival. Transplant Proc 34:1524-1525 (2002). PubMed PDF

151. Jain AB, Kashyap R, Demetris AJ, Eghtesad B, Pokharna R, Fung JJ. A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C. Liver Transplantation 8(1): 40-6 January 2002 PubMed PDF

152. Fung JJ, Jain AB , Kwak EJ, Kusne S, Dvorchik I, Eghtesad B. De novo malignancies after liver transplantation: A major cause of late death. Liver Transplantation 7(11)1, November 2001: S109-S118. PubMed PDF

153. Kashyap R, Jain AB, Nalesnik M, Carr BI, Barnes J, Vargas HE, Rakela J, Fung JJ. Clinical significance of elevated alpha-fetoprotein in adults and children. Digestive Diseases and Sciences 46(8): August 2001, 1709-1713. PubMed PDF

154. Jain AB, Nalesnik M, Reyes J, Pokharna R, Mazariegos G, Green M, Eghtesad B, Marsh W, Cacciarelli T, Fontes P, Abu-Elmagd K, Sindhi R, Demetris J, Starzl T and Fung J. Post-transplant lymphoproliferative disorders (PTLD) in liver transplantation (LTx): A twenty year experience. Annals of Surgery 236(4): October 2002, 429-437. PubMed PDF

155. Jain AB, Venkataramanan R, Shapiro R, Scantlebury VP, Potdar S, Bonham CA, Ragni M, Fung JJ. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. Liver Transplantation 8:(9); September 2002; 841-845. PubMed PDF

156. Jain AB, Venkataramanan R., Fridell JA, Eghtesad B, Ragni M, Fung JJ. Nelfinavir, a protease inhibitor, increases sirolimus levels in liver transplant patients: A case report. Liver Transplantation 8:(9) September 2002, 838-840. PubMed PDF

157. Agarwala S, Culligan E, Jain AB, McCauley J, Shapiro R, Chakrabarti P, Burckart G. Evaluation of renal function in transplant patients on chronic tacrolimus therapy. J Clinical Pharmacology 42:(7) 798-805, 2002. PubMed PDF

158. Demetris AJ, Ruppert K, Dvorchik I, Jain AB, Minevini M, Nalesnik, MA, Randhawa P, Wu T, Zeevi A, Abu-Elmagd K, Eghtesad B, Fontes PA, Cacciarelli TV, Marsh JW, Geller DA, Fung JJ. Real-Time Monitoring of Acute Liver-Allograft Rejection Using the Banff Schema. Transplantation 74(9):1290-1296, November 15, 2002. PDF

159. Jain AB, Eghtesad B, Venkataramanan R, Fontes PA, Kashyap R, Dvorchik I, Shakil AO, Kingery L and Fung JJ. Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection. Liver Transplantation 8:(11); November 2002: 1007-1013. PDF

160. Mazariegos GV, Salzedas, AA, Jain AB , and Reyes JA. Conversion from Cyclosporin to tacrolimus in paediatric liver transplant recipients. Paediatr Drugs 2001; 3(9):661-672. PubMed

161. Shapiro R, Jordan M, Scantlebury VP, Vivas CA, Jain AB, McCauley J, Egidi MF, Randhawa P, Chakrabarti P, Corry RJ. Renal allograft rejection with normal renal function in simultaneous kidney/pancreas recipients: Does dissynchronous rejection really exist? Transplantation 2000; 69(3):440-442. PubMed

162. Fridell JA, Bond GJ, Mazariegos GV, Jain AB et al Liver Transplantation in children with cystic fibrosis: a long term longitudinal review of a single centre experience. Journal of Pediatric Surgery 2003; 38 (8):1152 PDF

163. Shapiro R, Scantlebury VP, Jordan ML, Vivas CA, Jain AB, Hakala TR, McCauley J, Johnston J, Randhawa P, Fedorek S, Gray E, Chesky A, Dvorchik I, Donaldson J, Fung-JJ, and Starzl TE. A pilot trial of tacrolimus, sirolimus and steroids in renal transplant recipients. Transplant Proc 34:1651-1652 (2002). PDF

164. Jain AB, Venkataramanan R, Shapiro R, Scantlebury VP, Potdar S, Bonham CA, Pokharna R, Rohal S, Ragni M, and Fung JJ. Interaction between tacrolimus and antiretroviral agents in human immunodeficiency virus-positive liver and kidney transplantation patients. Transplant Proc 34:1540-1541 (2002). PubMed PDF

165. Fridell, J.A., A. K. Jain AB, Patel, K., Virji, M., Rao, K. N., Fung, J. J., Venkataramanan, R. (2003). “Phenytoin decreases the blood concentrations of sirolimus in a liver transplant recipient: a case report.” The Drug Monit 25 (1): 117-9. PDF

166. Jain AB. and J. J. Fung (2003). “Advances in hepatitis B virus infection.” Transplant Proc 35(1) 342-4. PubMed PDF

167. Jain AB and J. J. Fung (2003). “Alcoholic liver disease and transplantation.” Transplant Proc 35(1): 358-60. PubMed PDF

168. Jain AB. K. and J. J. Fung (2003). “Hepatitis C virus and renal failure.” Transplant Proc 35(1): 416-8. PubMed PDF

169. Eghtesad, B., Jain AB. and J. J. Fung (2003). “Living donor liver transplantation: ethics and safety.” Transplant Proc 35(1): 51-2. PubMed PDF

170. Mieles, L., S. Todo, Fung, J. J. , Jain AB., Furukawa, H., Susuki, M., Starzl, and T. E.(1990). “The side effects of FK 506 in humans.” Transplant Proc 22(1)” 41-3

171. Fridell, J. A., Jain AB , Reyes, J., Biederman, R., Green, M., Sindhi, R., Mazariegos, G.V. (2002). “Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus.” Transplantation 74(12):1721-4. PubMed PDF

172. Donnenberg, V.S., G. J. Burckart, Griffith, B. P., Jain AB., Zeevi, A., Berg, A.D. (2001). “P- glycoprotein (P-gp) is upregulated in peripheral T-cell subsets from solid organ transplant recipients” J Clin Pharmacol 41 (12): 1271-9. PubMed PDF

173. Venkataramanan, R., L. M. Shaw, Sarkozi, L., Mullins, R., Pirsch, J., MacFarlane, G., Scheller, D., Ersfeld, D., Frick, M., Fitzsimmons, W. E., Virji, M., Jain AB., Brayman, K. L., Shaked, A. (2001) “Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients” J Clin Pharmacol 41(5): 542-51. PubMed PDF

174. Jain A, Mazariegos G, Pokharna r, Parizhskaya M, Kashyap R, Kosmach-Park B, Smith A, Fung JJ, Reyes J., The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis. Transplant 2003 April 15; 75 (7):1020-5. PubMed PDF

175. Cataldo Doria, Jain AB, Victor L. Scott, Salvatore Gruttadauria, Ignazio R. Marino, Howard R. Doyle, John J. Fung, Conversion from tacrolimus to cyclosporine-A based immunosuppression following liver transplantation. Experimental and Clinical Transplantation (2003) 1:48-55.

176. Shullo MA, Rose ML, Vivas C, Jain AB, et al. Hemorrhagic complications of enoxaparin and aspirin in patients with kidney transplants. Pharmacotherapy 2002; 22 (2): 184 PubMed

177. Jain AB, Raman Venkataramanan, Bijan Eghtesad, Amadeo Marcos, Margaret Ragni, Ron Shapiro, Ann B. Rafail, and John J. Fung. Effect of Coadministered Lopinavir and Ritonavir (Kaletra) on Tacrolimus Blood Concentration in Liver Transplantation Patients. Liver Transplantation, Vol 9 (September), 2003: p 954-960. PubMed PDF

178. Jain AB, J. Reyes, Amadeo Marcos, G. Mazarigos, Bijan Eghtesad, Paulo A. Fontes, Thomas V. Cacciarelli, J. Wallis Marsch, Michael E. De Vera, Ann Rafail, Thomas E. Starzl, and John J. Fung. Pregnancy after Liver Transplantation with Tacrolimus Immunosppresion: A single Center’s Experience update at 13 years. Transplantation: Vol. 76, 827-932, No. 5, September 15, 2003. PubMed PDF

179. Yue, Z, Jain AB , Fung, J. J. Long-Term Survival after Liver Transplantation in 4000 Consecutive Patients at a Single Center . 12th Annual Meeting of the American Surgical Association, April 6-8, 2000, Pennsylvania . Ann Surg, Chin J., Volume 232 (4) October 2002. pp. 490-500.

180. Jain AB , Yue, Z, Chunping, J, Fung, J. J, Retransplantation-the only means to save recipients life after failure of liver transplantation: a report of 774 cases Chin J. Hepatobiliary Surg, Nov 2002, Vol. 8, No. 11.

181. Jain AB, Jorge Reyes, Randeep Kashyap, Susan Rohal, Kareem Abu-Elmagd, Thomas Starzl, John Fung. What Have We Learned About Primary Liver Transplantation Under Tacrolimus Immunosuppression? Long-Term Follow-up of the First 1000 patients. Ann Surg, Vol. 230 (3), (September), 1999: pp. 441-449. PubMed PDF

182. Jain AB, Jorge Reyes, Randeep Kashyap, Forrest Dobson, Anthony J. Demetris, Kris Ruppert, Kareem Abu-Elmagd, Wallis Marsh, Juan Madariaga, George Mazariegos, David Geller, C. Andrew Bonham, Timothy Gayowski, Thomas Cacciarelli, Paulo Fontes, Thomas E. Starzl, John Fung. Long-Term Survival after Transplantation in 4,000 Consecutive Patients at a Single Center. Ann Surg, Vol. 232 (4), (October), 2000: pp. 490-500 PubMed PDF

183. Jain AB, Mike Nalesnik, Jorge Reyes, Renu Pokharna, George Mazariegos, Michael Green, Bijan Eghtesad, Wallis Marsch, Thomas Cacciarelli, Paulo Fontes, Kareem Abu-Elmagd, Rakesh Sindhi, Jake Demetris, John Fung. Posttransplant Lymphoproliferative Disorders in Liver Transplantation: A 20 Year Experience. Ann Surg, Vol 236 (4), (October), 2002: pp. 429-437. PubMed PDF

184. Jain AB , Shapiro R, Scantlebury VP, Potdar S, Jordan ML, Flohr J, Marcos A, Fung JJ. Pregnancy after kidney and kidney-pancreas transplantation under tacrolimus: a single center's experience. Transplantation. 2004 Mar 27;77(6):897-902 PubMed PDF

185. Oruc MT , Soran A, Jain AB, Wilson JW, Fung J. De novo breast cancer in patients with liver transplantation: University of Pittsburgh 's experience and review of the literature. Liver Transpl. 2004 Jan;10(1):1-6. PubMed PDF

186. Bozorgzadeh Adel, Jain, Ashok, Ryan Charlotte, Ornt Daniel, Zand Martin, Mantry Parvez, Lansing Kerrie, Orloff Mark Impact of hepatitis c viral infection in primary cadaveric liver allograft versus primary living-donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus. Transplantation. 2004 April 15;77(7):1066-1071 PubMed PDF

187. Luke PP, Herz DB, Bellinger MF, Chakrabarti P, Vivas CA, Scantlebury VP, Hakala TR, Jevnikar AM, AB Jain, Shapiro R, Jordan ML. Long-term results of pediatric renal transplantation into a dysfunctional lower urinary tract. Transplantation. 2003 Dec 15;76(11):1578-82 PubMed PDF

188. Eghtesad B, Marsh WJ, Cacciarelli T, Geller D, Reyes J, AB Jain, Fontes P, Devera M, Fung J. Liver transplantation for growing teratoma syndrome: report of a case. Liver Transpl. 2003 Nov;9(11):1222-4. PubMed PDF

189. Kareem M. Abu-Elmagd, Marsh Zak, June M. Stamos, Geoff J. Bond, AB Jain, Ada O. Youk, Mohamed Ezzelarab, Guilherme Costa, Tong Wu, Michael A. Nalesnik, Anthony J. Demetris, and Jorge D. Reyes. De novo malignancies after intestinal and multivisceral transplantation. Transpl. 2004 June;15 (77): 1719-1725. PubMed PDF

190. Jaya Pisupati, AB Jain, Gilbert Burlkart, Imad Hamad, Sheila Zucuerman, John Fung, Raman Venkataramanan. Intra and inter-individual variations in the pharmacokinetics of mycophenolic acid in liver transplant patients. Journal of Clinical Pharmacology 2005; 45 (1): 34 PubMed PDF

191. DiMartini, Dew MA, Javed L, Fitzgerald MG, Jain A, Day N. Pretransplant psychiatric and medical comorbidity of alcoholic liver disease patients who received liver transplant. Psychosomatics 2004; 45 (6):517 PubMed PDF

192. Pan C, Jain A, Fung JJ. Analysis of causes of late mortality in liver transplant recepients. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2004; 16 (9): 547 PubMed

193. Cataldo Doria, Ashok Kumar B. Jain, Victor L. Scott, Salvatore Gruttadauria, Ignazio R. Marino1, Howard R. Doyle, John J. Fung Conversion From Tacrolimus to Cyclosporine-A Based Immunosuppression Following Liver Transplantation Experimental and Clinical Transplantation (2003) 1: 48-55 PubMed PDF

194. Ashokkumar Jain, Amadeo Marcos, Reye S, George Mazariagos, Randeep Kashyap, Bijan Eghtesad, Wallis Marsh, Paulo Fontas, Mike De Vera, Guilheme Costa, Kusum Patel, Mary Gadomski, Thomas Starzl, John Fung. Tacrolimus for Primary liver Transplantation: 12 to 15 years actual followup with safety profile. Transplantation Proceedings 2005; 37(2): 1207-10 PubMed PDF

195. Ashokkumar Jain, Raman Vekatramanan, Barbara Yelochan, Randeep Kashyap, Amadeo Marcos, John Fung. Ribavarin levels in post Liver transplant (LTx) patients treated for recurrent hepatitis C viral (HCV) infection. Transplantation Proceedings 2005 Sep;37(7):3190-6 PubMed PDF

196. Ashokkumar Jain, Mark Orloff, Randeep Kashyap, Kerrie Lansing, Robert Betts, Merelyn Menegus, Charlotte Ryan, Adel Bozorgzadeh. Does Valganciclovier hydrochloride (Valcyte™) provide effectie prophylaxis against Cytomegalovirus (CMV) infection in liver transplant recepients? Transplantation Proceedings 2005 Sep;37(7):3182-6 PubMed PDF

197. Ashokkumar Jain, Mark Orloff, Peter Abt, Randeep Kashyap, Kerrie Lansing, Joan Romano, Adel Bozorgzadeh. Survival outcome after hepatic retransplantation for Hepatitis C viral positive and negative recepients. Transplantation Proceedings 2005 Sep;37(7):3159-61 PubMed PDF

198. Ashokkumar Jain, Mark Orloff, Peter Abt, Randeep Kashyap, Kerrie Lansing, Mark Kelley, Adel Bozorgzadeh.Use of Hepatitis B core antibody positive liver allograft in hepatitis C viral (HCV) positive and HCV negative recepients with use of short course of hepatitis B immunoglobulin (HBIg) and Lamivudine. Transplantation Proceedings 2005 Sep;37(7):3187-9 PubMed PDF

199. Ashokkumar Jain, Mark Orloff, Peter Abt, Randeep Kashyap, Kerrie Lansing, Adel Bozorgzadeh. Impact of older donor graft in Liver transplantation with Hepatitis C viral infection. Transplantation Proceedings 2005 Sep;37(7):3162-4 PubMed PDF

200. Kelly M, Jain A, Kashyap R, Orloff M, abt P, Wrobble K, Venkatramanan R, Bozorgzadeh A. Changes in oral absorption of Tacrolimus in post-Liver transplant patients after reversal of Jejunoileal (JI) bypass: case report Transplantation Proceedings 2005 Sep;37(7):3165-7 PubMed PDF

201. Dimartini A, Javed L, Russell S, Dew MA, Fitzgerald MG, Jain A, Fung J. Tobacco use following liver transplantation for alcoholic liver disease: An underestimated problem. Liver Transplantation 2005; Jun; 11(6); 679-83 PubMed PDF

202. Ashokkumar Jain, Raman Vekatramanan, Bijan Eghtesad, Mary Gadomski, Ravi Mohanka, Amadeo Marcos, John Fung. Long term outcome of adding mycophenolate mofetil (MMF) to tacrolimus for nephrotoxicity following liver transplantation (LTx). Transplantation 2005 Sep 27;80(6):859-864 PubMed PDF

203. Shah A, Kendall G, Demme RA, Taylor J, Bozorgzadeh A, Orloff M, Jain A, Abt P, Zand MS. Home glucometer monitoring markedly improves diagnosis of post renal transplant diabetes mellitus in renal transplant recipients. Transplantation. 2005 Sep 27;80(6):775-81 PubMed PDF

204. Ashokkumar B. Jain, Amadeo Marcos, Renu Pokharna, Ron Shapiro, Paulo A. Fontes, Wallace Marsh, Ravi Mohanka, John J. Fung. Rituximab (chimeric anti-CD20 antibody) for post transplant lymphoproliferative disorder (PTLD) after solid organ transplantation in adults: long term experience. Transplantation 2005 Dec 27;80(12):1692-1698 PubMed PDF

205. Ashokkumar Jain, Guilherme Costa, Wallis Marsh, Paulo Fontes, Michael Devera, George Mazariegos, Jorge Reyes, Kusum Patel, Ravi Mohanka, Mary Gadomski, John Fung, Amadeo Marcos. Thrombotic and non-thrombotic hepatic artery complications in adults and children following primary liver transplantation with long term follow-up in 1000 consecutive patients. Transplant International 2006 Jan;19(1):27-37 PubMed PDF